As a result of these properties, NanoICD/CAT-PCA efficiently elicited protective cognate antitumor immunity against tumor rechallenge (Fig. 7F) and tumor lung metastasis (Fig. 7G). The gene discussed is FLVCR1; the disease is neoplasm.